Tolerance intervals for assessing individual bioequivalence

Statistics in Medicine

Volumn 16, Issue 7, 1997, Pages 803-820

  Brown, Eileen B ^a   Iyer, Hari K ^a   Wang, C Ming ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; COMPARATIVE STUDY; DRUG FORMULATION; DRUG TOLERANCE; MATHEMATICAL MODEL;

CHEMISTRY, PHARMACEUTICAL; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; DRUG INTERACTIONS; HUMANS; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY;

EID: 0030935677     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970415)16:7<803::AID-SIM499>3.0.CO;2-3     Document Type: Article

References (28)

1. Westlake, W. J. 'Use of confidence intervals in analysis of comparative bioavailability trials', Journal of Pharmaceutical Sciences, 61, 1340-1341 (1972).
2. Westlake, W. J. 'Symmetrical confidence intervals for bioequivalence trials', Biometrics, 32, 741-744 (1976).
3. Metzler, C. M. 'Bioavailability - a problem in equivalence', Biometrics, 30, 309-317 (1974).
4. Schuirmann, D.J. 'A comparison of the two one-sided procedure and the power approach for assessing the equivalence of average bioavailability', Journal of Pharmacokinetics and Biopharmaceutics, 15, 657-680 (1987).
5. Anderson, S. and Hauck, W. W. 'Consideration of individual bioequivalence', Journal of Pharmacokinetics and Biopharmaceutics, 18, 259-274 (1990).
6. Sheiner, L. B. 'Bioequivalence revisited', Statistics in Medicine, 11, 1777-1788 (1992).
7. Schall, R. and Luus, H. G. 'On population and individual bioequivalence', Statistics in Medicine, 12, 1109-1124 (1993).
8. Schall, R. 'Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar', Biometrics, 51, 615-626 (1995).
9. Haynes, J. D. 'Statistical simulation study of new proposed uniformity requirement for bioequivalency studies', Journal of Pharmaceutical Sciences, 70, 673-675 (1981).
10. Metzler, C. M. and Huang, D. C. 'Statistical methods for bioavailability and bioequivalence', Clinical Research Practices & Drug Regulatory Affairs, 1, 109-132 (1983).
11. Westlake, W. J. 'Statistical aspects of comparative bioavailability trials'. Biometrics, 35, 273-280 (1979).
12. Westlake, W. J. 'Bioavailability and bioequivalence of pharmaceutical formulations', in Peace K. E. (ed), Pharmaceutical Statistics for Drug Development, Marcel Dekker, New York, 1988, pp. 329-352.
13. Hwang, S., Huber, P. B., Hesney, M. and Kwan, K. C. 'Bioequivalence and interchangeability', Journal of Pharmaceutical Sciences, 67, iv (1981).
14. Ekbohm, G. and Melander, H. 'The subject-by-formulation interaction as a criterion of interchangeability of drugs', Biometerics, 45, 1249-1254 (1989).
15. Gaffney, M. 'Variance components in comparative bioavailability studies', Journal of Pharmaceutical Sciences, 81, 315-317 (1992).
16. Esinhart, J. D. and Chinchilli, V. M. 'Extension to the use of tolerance intervals for the assessment of individual bioequivalence', Journal of Biopharmaceutical Statistics, 4, 39-52 (1994).
17. Chow, S. C. and Liu, J. P. Design and Analysis of Bioavailability and Bioequivalence Studies, Marcel Dekker, New York, 1992.
18. Cody, R. L. and Slack, M. K. 'Crossover design in pharmacy research', Annals of Pnharmacotherapy, 26, 327-333 (1992).
19. Holder, D. J. and Hsuan, F. 'Moment-based criteria for determining bioequivalence', Biometrika, 80, 835-846 (1993).
20. Pabst, G. and Jaeger, H. 'Review of methods and criteria for the evaluation of bioequivalence studies', European Journal of Clinical Pharmacology, 38, 5-10 (1990).
21. Midha, K. K., Ormsby, E. D., Gubbard, J. W., McKay, G., Hawes, E. M., Gavalas, L. and McGilveray, I. J., 'Logarithmic transformation in bioequivalence: application with two formulations of perphenazine', Journal of Pharmaceutical Sciences, 82, 138-144 (1993).
22. Chow, S. C. and Liu, J. P. 'Recent statistical developments in bioequivalence trials-A review of the FDA guidance', Drug Information Journal, 28, 851-864 (1994).
23. Liu, J. P. and Weng, C. S. 'Evaluation of log-transformation of assessing bioequivalence', Communications in Statistics - Theory and Methods, 23, 421-434 (1994).
24. Wang, C. M. and Iyer, H. K. 'Tolerance intervals of the distribution of true values in the presence of measurement errors', Technometrics, 36, 162-170 (1994).
25. Hahn, G. J. and Meeker, W. Q. Statistical Intervals, A Guide for Practitioners, Wiley, New York, 1991.
26. Chow, S. C. and Liu, J. P. 'On assessment of bioequivalence under a higher-order crossover design', Journal of Biopharmaceutical Statistics, 2, 239-256 (1992).
27. Grahnén, A., Hammarlund, M. and Lundqvist, T. 'Implications of intraindividual variability in bioavailability studies of flurosemide',European Journal of Clinical Pharmacology, 27, 595-602 (1984).
28. Satterthwaite, F. E. 'An approximate distribution of estimates of variance components', Biometrics, Bulletin, 2, 110-114 (1946)